• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Pilot Study Showcases the Value of Portrait Mobile Continuous Monitoring Solution to Encourage Clinical Intervention While Mitigating Alarm Fatigue

    11/18/24 8:00:00 AM ET
    $GEHC
    Medical Electronics
    Health Care
    Get the next $GEHC alert in real time by email
    • Published in the Journal of Clinical Anesthesia, results from the two-phase, 250 patient pilot study show clinicians found a majority (82%) of the alarms from the wireless and wearable Portrait Mobile monitoring solution to be informative or useful to optimize patient care in medical-surgical units.1
    • Study findings suggest that continuous monitoring helps provide critical information to clinicians, enabling them to intervene effectively before a patient deteriorates.
    • Undetected patient deterioration, particularly post-surgery, can lead to hazardous yet preventable consequences, with 30-day mortality after surgery representing the third leading cause of death globally.2

    GE HealthCare (NASDAQ:GEHC) today announced the publication of data from a two-phase pilot study conducted with Cleveland Clinic in the peer-reviewed Journal of Clinical Anesthesia, highlighting performance of the wireless and wearable Portrait™ Mobile monitoring solution in the post-surgical ward environment.

    With published alarm rates from critical care and cardiac telemetry units that number in the hundreds per bed per day, healthcare systems may be concerned with alarm management in lower acuity settings.3,4 The results from this study highlight the potential of the wireless and wearable Portrait Mobile monitoring solution to provide meaningful alarms for clinicians and help encourage clinical intervention while minimizing alarm fatigue.1

    The COSMOS (Continuous Ward Monitoring with the GE HealthCare Portrait Mobile Monitoring Solution) pilot study compares continuous monitoring with Portrait Mobile to routine intermittent vital signs assessment only. Key findings include:

    • In the Portrait Mobile group, there was an average of less than three alarms per patient per day.
    • Clinicians found a majority (82%) of the Portrait Mobile alarms to be informative or useful.
    • Portrait Mobile alarms informed clinical decisions, and the most common nursing intervention was the initiation of oxygen therapy or increase in the concentration of oxygen administered to a patient. Clinicians were prompted to supplement oxygen in about 60% more patients assigned to the Portrait Mobile group compared to patients with intermittent monitoring only (49 vs. 33, respectively).
    • In the Portrait Mobile group, continuous monitoring and alerts led to clinical interventions that reduced vital sign abnormalities by approximately 25%.

    "Vital signs are typically checked every 4-6 hours after surgery. Consequently, there can be a delay between onset of problems and when they are recognized by physicians and nurses," shares Principal Investigator Daniel I. Sessler, MD, formerly with Cleveland Clinic and now Professor and Vice President for Clinical and Outcomes Research at UTHealth Houston.* "Results of our COSMOS study indicate that continuous vital sign monitoring provides useful information to clinicians without burdening nurses."

    The results from the COSMOS Phase 2 pilot were recently presented during the American Society of Anesthesiologists 2024 Annual Meeting in Philadelphia. The Phase 2 pilot enrolled 150 post-surgical patients who were randomized to routine vital signs assessment, or continuous monitoring of respiratory rate, oxygen saturation and pulse rate with Portrait Mobile. In the Portrait Mobile group, investigators alerted clinicians when vital sign values exceeded the designated thresholds based on continuous monitoring. In both groups, clinicians maintained routine care of vital signs measurement at 4-hour intervals. The study demonstrated that real-time alerts from Portrait Mobile reduces the duration and severity of vital sign abnormalities. Following the COSMOS pilot completion, a full clinical trial is currently underway (NCT06133140).

    Continuous vital sign monitoring can help alert healthcare providers to a patient's decline as it is happening, enabling timely intervention before a patient deteriorates. A majority of respondents (74%) of GE HealthCare's The State of Flexible Healthcare Delivery survey say that expanding the use of continuous monitoring technologies within healthcare systems would help identify deterioration earlier.

    "As healthcare systems grapple with workforce shortages and complex patient management, it is essential that providers be supported by technology to work efficiently and effectively. In the ward environment where bedside clinicians are responsible for multiple patients simultaneously, care should be focused on the patients who need it most, and this requires ongoing surveillance and communication," said John Beard, MD, Chief Medical Officer of Patient Care Solutions, GE HealthCare.

    "Continuous physiologic monitoring solutions can meet the challenge to alert care teams for changes in patient status but must be properly configured to optimize actionable alarms and clinical value. These research findings demonstrate that Portrait Mobile can meet the needs of patients and clinicians and provide critical information to support clinical decision making without causing undue burden."

    Portrait Mobile is part of GE HealthCare's FlexAcuity monitoring solutions that are engineered to adapt to rapidly changing patient needs. GE HealthCare's technology has been recognized globally for its design, receiving the iF Design Gold Award for Product Design in 2022 for Portrait Mobile and an iF Design Award in 2023 for CARESCAPE Canvas.

    For more information on Portrait Mobile and GE HealthCare's family of Portrait monitoring solutions, please visit: https://www.gehealthcare.com/products/patient-monitoring/portrait-mobile

    *The COSMOS study was funded by GE HealthCare. The views expressed are solely those of Dr. Daniel Sessler, do not reflect the opinions or beliefs of UTHealth Houston and are based on his own opinions and on results that were achieved in the trial. Since there is no "typical" hospital/clinical setting and many variables exist, i.e. hospital size, case mix, staff expertise, etc. there can be no guarantee that others will achieve the same results.

    About GE HealthCare Technologies Inc.

    GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient's journey across the care pathway. Together our Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a $19.6 billion business with approximately 51,000 colleagues working to create a world where healthcare has no limits.

    Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website https://www.gehealthcare.com for more information.

    1 Anusic N, et al. Continuous vital sign monitoring on surgical wards: The COSMOS pilot. J Clin Anesth. 2024 Nov 11;99:111661. doi: 10.1016/j.jclinane.2024.111661. Epub ahead of print. PMID: 39531997.

    2 Nepogodiev D, et al. National Institute for Health Research Global Health Research Unit on Global Surgery. Global burden of postoperative death. Lancet. 2019;393(10170):401.

    3 Gross B, Dahl D, Nielsen L. Biomed Instrum Technol. Physiologic monitoring alarm load on medical/surgical floors of a community hospital. Spring. 2011;Suppl:29-36. doi: 10.2345/0899-8205-45.s1.29. PMID: 21599479.

    4 Physician-Patient Alliance for Health & Safety. ‘Alarm fatigue' a top-of-mind concern for U.S. hospitals, finds national survey presented at Society for Technology in Anesthesia Annual Meeting. Published January 2014. Accessed October 6, 2023. https://ppahs.org/2014/01/alarm-fatigue-a-top-of-mind-concern-for-u-s-hospitals-finds-national-survey-presented-at-society-for-technology-in-anesthesia-annual-meeting/

    View source version on businesswire.com: https://www.businesswire.com/news/home/20241118649936/en/

    Get the next $GEHC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GEHC

    DatePrice TargetRatingAnalyst
    1/15/2026$77.00Neutral → Sell
    UBS
    10/13/2025$86.00Equal Weight
    Barclays
    10/7/2025$83.00Buy → Neutral
    Citigroup
    5/5/2025$73.00Sell → Neutral
    UBS
    3/11/2025$85.00 → $100.00Neutral → Buy
    Goldman
    1/8/2025$95.00 → $103.00Hold → Buy
    Jefferies
    9/26/2024$84.00 → $74.00Neutral → Sell
    UBS
    9/18/2024$100.00Neutral → Buy
    BTIG Research
    More analyst ratings

    $GEHC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Jimenez Frank R bought $100,624 worth of shares (1,315 units at $76.52), increasing direct ownership by 2% to 75,796 units (SEC Form 4)

    4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)

    5/2/24 6:00:38 AM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    GE HealthCare downgraded by UBS with a new price target

    UBS downgraded GE HealthCare from Neutral to Sell and set a new price target of $77.00

    1/15/26 8:32:16 AM ET
    $GEHC
    Medical Electronics
    Health Care

    Barclays initiated coverage on GE HealthCare with a new price target

    Barclays initiated coverage of GE HealthCare with a rating of Equal Weight and set a new price target of $86.00

    10/13/25 8:53:16 AM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare downgraded by Citigroup with a new price target

    Citigroup downgraded GE HealthCare from Buy to Neutral and set a new price target of $83.00

    10/7/25 8:57:17 AM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO, Patient Care Solutions Bankes Jeannette was granted 6,861 shares, increasing direct ownership by 19% to 43,892 units (SEC Form 4)

    4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)

    3/4/26 4:27:18 PM ET
    $GEHC
    Medical Electronics
    Health Care

    GC & Corporate Secretary Jimenez Frank R was granted 10,915 shares, increasing direct ownership by 13% to 92,182 units (SEC Form 4)

    4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)

    3/4/26 4:26:57 PM ET
    $GEHC
    Medical Electronics
    Health Care

    Chief Technology Officer Kass-Hout Taha was granted 13,254 shares, increasing direct ownership by 17% to 92,909 units (SEC Form 4)

    4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)

    3/4/26 4:26:16 PM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $GEHC
    SEC Filings

    View All

    GE HealthCare announces U.S. FDA 510(k) clearance for View, a next‑generation diagnostic viewer enabling anywhere‑access to radiologists

    Built for the demands of modern imaging, View streamlines workflows, and helps enhance patient care as the advanced diagnostic viewer powering the Genesis Radiology Workspace GE HealthCare today announced that View, the powerful viewer within the Genesis™ Radiology Workspace, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Designed as a fast, diagnostic, zero‑footprint viewer, View serves as the core anchor of the Genesis Radiology Workspace.2 This next‑generation solution aims to transform radiology workflows, unify the user experience, and empower radiologists with greater efficiency and precision. Studies show that radiologists spend up to 44% of the

    3/9/26 9:00:00 AM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare to showcase AI and digital leadership at HIMSS 2026

    Booth #2525 will highlight the company's AI-powered, cloud-first and software solutions intended to help teams access data and insights more efficiently GE HealthCare (NASDAQ:GEHC) will showcase innovations moving healthcare forward at the Health Information and Management Systems Society (HIMSS) Global Health Conference & Exhibition 2026 in Las Vegas from March 9-12, 2026. This year, GE HealthCare will spotlight meaningful technology transforming the way healthcare professionals approach patient care, from imaging operations and fleet management to enterprise solutions, ultrasound, and patient care technologies. The healthcare industry continues to confront worsening workforce gaps w

    3/5/26 9:00:00 AM ET
    $GEHC
    Medical Electronics
    Health Care

    Hospital Networks Turn to AI-Enhanced Cardiac Imaging to Cut Costs and Improve Outcomes

    Issued on behalf of VentriPoint Diagnostics Ltd.VANCOUVER, BC, March 3, 2026 /CNW/ -- USANewsGroup.com News Commentary -- AI is making its way through the halls of our entire medical system, and the implementation is accelerating at a great pace. The AI medical imaging market is projected to hit nearly $20 billion by 2033, growing at a 34.7% CAGR[1]. Echocardiography alone is forecast to grow to $2.64 billion by 2030 as hospitals demand cardiac platforms that prove economic value alongside clinical accuracy[2]. Companies like VentriPoint Diagnostics (TSXV:VPT) (OTCPK: VPTDF), Butterfly Network (NYSE:BFLY), Tempus AI (NASDAQ:TEM), RadNet (NASDAQ:RDNT), and GE HealthCare (NASDAQ:GEHC) are conv

    3/3/26 12:19:00 PM ET
    $BFLY
    $GEHC
    $RDNT
    Medical Electronics
    Health Care
    Medical Specialities
    Computer Software: Programming Data Processing

    Amendment: SEC Form SCHEDULE 13G/A filed by GE HealthCare Technologies Inc.

    SCHEDULE 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

    2/13/26 1:22:49 PM ET
    $GEHC
    Medical Electronics
    Health Care

    SEC Form 10-K filed by GE HealthCare Technologies Inc.

    10-K - GE HealthCare Technologies Inc. (0001932393) (Filer)

    2/4/26 6:28:06 AM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - GE HealthCare Technologies Inc. (0001932393) (Filer)

    2/4/26 6:25:33 AM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Leadership Updates

    Live Leadership Updates

    View All

    PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer

    BOCA RATON, Fla., June 2, 2025 /PRNewswire/ -- PharmaLogic Holdings Corp. ("PharmaLogic" or "the Company"), a leading contract development and manufacturing organization (CDMO) specialized in radiopharmaceuticals, today announces the Company has appointed Etienne Montagut, currently serving as President, to the position of President and Chief Executive Officer, effective as of 1 June 2025. Mr. Montagut brings over 25 years of senior leadership experience in the pharmaceutical sector, with a solid track record of driving growth and executing strategic transformation across glob

    6/2/25 8:00:00 AM ET
    $GEHC
    $LNTH
    Medical Electronics
    Health Care
    Biotechnology: In Vitro & In Vivo Diagnostic Substances

    GE HealthCare names Jeannette Bankes president and CEO, Patient Care Solutions

    GE HealthCare (NASDAQ:GEHC), a leading global healthcare solutions provider, announced the appointment of Jeannette Bankes as president and CEO, Patient Care Solutions, effective May 1, 2025. Peter Arduini, president and CEO, GE HealthCare, said, "Jeannette is a proven leader who has diverse and deep experience at publicly traded companies in the healthcare industry. We proudly welcome her to the company and are confident that she has the expertise to move Patient Care Solutions forward and deliver on our precision care strategy." Bankes brings with her three decades of global experience including product management, marketing, sales, regulatory, medical affairs, and operations and manufa

    4/9/25 9:00:00 AM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare's MIM Software collaborates with Elekta to help enhance radiation therapy treatments and improve patient outcomes

    Collaboration has always been important in the healthcare industry, but in this era of digital health, teamwork across institutions has become essential Enhancing Elekta's radiation therapy offerings with GE HealthCare's MIM Software medical imaging management solutions will help drive greater benefits for global healthcare systems This new collaboration complements GE HealthCare and Elekta's existing global commercial collaboration agreement, which enables the two companies to provide hospitals and cancer patients a comprehensive radiation therapy offering across imaging and treatment Weeks after closing its acquisition of MIM Software – a global provider of medical imaging analy

    4/22/24 7:07:00 AM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by GE HealthCare Technologies Inc.

    SC 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

    11/12/24 12:53:28 PM ET
    $GEHC
    Medical Electronics
    Health Care

    Amendment: SEC Form SC 13G/A filed by GE HealthCare Technologies Inc.

    SC 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

    10/22/24 4:16:16 PM ET
    $GEHC
    Medical Electronics
    Health Care

    SEC Form SC 13G/A filed by GE HealthCare Technologies Inc. (Amendment)

    SC 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

    4/2/24 4:07:29 PM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Financials

    Live finance-specific insights

    View All

    GE HealthCare announces cash dividend for first quarter of 2026

    The Board of Directors of GE HealthCare Technologies Inc. (NASDAQ:GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the first quarter of 2026 payable on May 15, 2026, to all shareholders of record as of April 3, 2026. About GE HealthCare Technologies Inc. GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world's most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Imaging, Advanced Visualization Solutions, Patie

    2/12/26 6:11:00 PM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare reports fourth quarter and full year 2025 financial results

    Company exceeds topline and earnings per share expectations; demonstrates operational resilience Fourth quarter 2025 highlights(1) Revenue growth of 7.1%, including Organic revenue growth* of 4.8%, driven primarily by the U.S. and Europe, the Middle East and Africa (EMEA) Net income margin of 10.3% and Adjusted earnings before interest and taxes (EBIT) margin* of 16.7% Diluted earnings per share (EPS) of $1.29 and Adjusted EPS* of $1.44 Cash flow from operating activities of $1.0 billion and Free cash flow* of $916 million Full year 2025 highlights(1) Revenue growth of 4.8%, including Organic revenue growth* of 3.5% Organic orders growth of 5.2% Net income margin o

    2/4/26 6:20:00 AM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare to announce fourth quarter and full year 2025 results on February 4, 2026

    GE HealthCare (NASDAQ:GEHC) will announce its fourth quarter and full year 2025 financial results before the market opens on Wednesday, February 4, 2026. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay also will be posted at the same link on the GE HealthCare Investor Relations website. About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innova

    1/5/26 8:00:00 AM ET
    $GEHC
    Medical Electronics
    Health Care